国产创新药迎利好密集期!九安医疗产品获FDA批准,一品红斩获近70亿元大单

21世纪经济报道
Dec 15, 2025

12月14日晚,多只医药股发布利好消息。九安医疗公告,公司美国子公司四联检、三联检产品获得美国FDA上市前通知,涉及的产品包括甲型流感、乙型流感、COVID-19及RSV呼吸道合胞病毒四联检测家用试剂盒等。这些产品取得上市前通知后,均可在美国市场正常销售。2025年被称为“国产流感新药元年”,据头豹研究院预测,2024~2028年中国抗流感用药市场规模有望以年复合增长率20.2%持续增长,预计...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10